Omkar Pharmachem Limited has submitted a regulatory intimation to BSE Limited regarding an upcoming board meeting. The meeting of the Board of Directors is scheduled for Saturday, November 14, 2026, at 04:30 P.M. at the company's registered office.
The primary agenda for the board meeting is to consider, approve, and take on record the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2026.
Additionally, the company confirms the continuation of the trading window closure for dealing in shares of the Company. Pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company, the trading window shall remain closed until November 16, 2026 (inclusive) for all Designated Persons of the Company and their Immediate Relatives. This extends the previously announced closure from September 26, 2026.
The disclosure is made pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is digitally signed by Bhawani S Goyal, Managing Director (DIN: 03255804).